Literature DB >> 8068575

Sudden death caused by thrombosed coronary artery aneurysm. Two unusual cases of Kawasaki disease.

I B Kristensen1, B O Kristensen.   

Abstract

Kawasaki disease primarily affects children below 5 years of age, and fatal coronary complications usually occur within 6-12 months following the acute illness. We report 2 unusual fatal cases of thrombosed coronary artery aneurysms. The first case was an 11-year-old boy, who died suddenly 2 months after the acute illness. He had a classical clinical picture, but was misdiagnosed. The second case was a 29-year-old man without history of recent febrile episodes or cardiac symptoms. Both subjects fulfilled the stage 4 criteria of Kawasaki disease (healing stage) with extensive old myocardial damage. The cases illustrate the great variation in the clinical picture of Kawasaki disease. Teenagers can also be affected, and extensive myocardial damage may be asymptomatic for many years.

Entities:  

Mesh:

Year:  1994        PMID: 8068575     DOI: 10.1007/bf01225421

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  10 in total

1.  Coronary artery aneurysms in a young adult.

Authors:  T C Schultz
Journal:  Am J Forensic Med Pathol       Date:  1989-03       Impact factor: 0.921

2.  Sudden death caused by coronary artery aneurysms: a late complication of Kawasaki disease.

Authors:  F S Wreford; S E Conradi; S D Cohle; J T Lie; S E Dana; S Puri
Journal:  J Forensic Sci       Date:  1991-01       Impact factor: 1.832

3.  Mortality among children with Kawasaki disease in Japan.

Authors:  Y Nakamura; H Yanagawa; T Kawasaki
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

4.  Long-term prognosis of Kawasaki disease patients with coronary artery obstruction.

Authors:  K Tatara; S Kusakawa; K Itoh; N Kazuma; K Lee; K Hashimoto; T Shinohara; C Kondoh; M Hiroe
Journal:  Heart Vessels       Date:  1989       Impact factor: 2.037

Review 5.  Diagnosis and management of Kawasaki disease.

Authors:  W M Gersony
Journal:  JAMA       Date:  1991 May 22-29       Impact factor: 56.272

6.  Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease.

Authors:  G Koren; V Rose; S Lavi; R Rowe
Journal:  JAMA       Date:  1985-08-09       Impact factor: 56.272

7.  Asymptomatic myocardial infarction in Kawasaki disease: long-term prognosis.

Authors:  I Shiraishi; Z Onouchi; T Hayano; K Hamaoka; N Kiyosawa
Journal:  Pediatr Cardiol       Date:  1991-04       Impact factor: 1.655

8.  Transformation of coronary artery aneurysm to obstructive lesion and the role of collateral vessels in myocardial perfusion in patients with Kawasaki disease.

Authors:  Z Onouchi; K Hamaoka; Y Kamiya; S Hayashi; Y Ohmochi; K Sakata; I Shiraishi; T Hayano; H Fukumochi
Journal:  J Am Coll Cardiol       Date:  1993-01       Impact factor: 24.094

9.  Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease.

Authors:  T Fujiwara; H Fujiwara; Y Hamashima
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

10.  Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis.

Authors:  T Fujiwara; H Fujiwara; H Nakano
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

  10 in total
  3 in total

1.  Effect of adopting a new histological grading system of acute rejection after heart transplantation.

Authors:  A H Balk; P E Zondervan; P van der Meer; T van Gelder; B Mochtar; M L Simoons; W Weimar
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

Review 2.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

3.  Giant right coronary artery aneurysm presenting as a mediastinal mass.

Authors:  P Banerjee; T Houghton; M Walters; G C Kaye
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.